Roche considers options for $1.9bn cancer data start-up https://t.co/oTwmBoQQ0i $ROG.SW | $RO.SW | $RHHBY 🇨🇭 Roche https://t.co/QhW68hDQ5J

Reuters@Reuters

1 year ago

Roche considering divesting $1.9 bln cancer data startup, FT reports https://t.co/rHU9wEjD5U https://t.co/UGXtxvb49k

Roche considers options for $1.9bn cancer data start-up: “Despite Flatiron struggling to make money, one benefit of the acquisition is that its data has helped to improve cancer drug development at Roche” https://t.co/zWTHgHpwYJ